Literature DB >> 13457840

Lupus erythematosus disseminatus after administration of mesantoin; report of two cases.

T LINDQVIST.   

Abstract

Entities:  

Keywords:  HYDANTOINS/injurious effects; LUPUS ERYTHEMATOSUS, DISSEMINATED/etiology and pathogenesis

Mesh:

Substances:

Year:  1957        PMID: 13457840     DOI: 10.1111/j.0954-6820.1957.tb15754.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


× No keyword cloud information.
  9 in total

Review 1.  Drug-induced lupus anticoagulants and antiphospholipid antibodies.

Authors:  Jeffrey S Dlott; Robert A S Roubey
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

2.  Lymphocytotoxins in epileptic patients receiving phenytoin.

Authors:  B S Ooi; K S Kant; I B Hanenson; A J Pesce; V E Pollak
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

3.  Neuropsychiatric problems in systemic lupus erythematosus.

Authors:  R Bennett; G R Hughes; E G Bywaters; P J Holt
Journal:  Br Med J       Date:  1972-11-11

4.  Antinuclear antibodies in patients on anticonvulsant therapy.

Authors:  D Alarcón-Segovia; E Fishbein; P A Reyes; H Díes; S Shwadsky
Journal:  Clin Exp Immunol       Date:  1972-09       Impact factor: 4.330

5.  Natural antibodies to procaine amide.

Authors:  A S Russell; M Ziff
Journal:  Clin Exp Immunol       Date:  1968-11       Impact factor: 4.330

6.  Occurrence, immunoglobulin pattern and specificity of antinuclear antibodies in sera of procaine amide treated patients.

Authors:  A Klajman; N Camin-Belsky; A Kimchi; S Ben-Efraim
Journal:  Clin Exp Immunol       Date:  1970-11       Impact factor: 4.330

Review 7.  Drug-induced lupus.

Authors:  E J Price; P J Venables
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

8.  Immunological abnormalities and hydantoins.

Authors:  P J Grob; G E Herold
Journal:  Br Med J       Date:  1972-06-03

Review 9.  Are there environmental forms of systemic autoimmune diseases?

Authors:  E V Hess
Journal:  Environ Health Perspect       Date:  1999-10       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.